Tuesday, April 22, 2025
Blogger Facebook Linkedin Pinterest Twitter Youtube

Tag: CSIR-Central Drug Research Institute (CDRI)

Umifenovir

Umifenovir gets DCGI approval for Phase III clinical trial

HTP Desk - 0
CSIR constituent lab CSIR-Central Drug Research Institute (CDRI) Lucknow has received permission for carrying out Phase III randomized, Double-blind, Placebo-controlled trial of efficacy, safety,...
Healthtekpak delivers daily news, updates, analysis, case studies and industry scoops related to the health industry.
Contact us: editor@ippgroup.in
Blogger Facebook Linkedin Pinterest Twitter Youtube
© 2024 All content (text and/or media) is intellectual property of IPP Catalog Publications Pvt. Ltd.

This function has been disabled for HealthTekPak.

error: Content is protected !!